DK171300B1 - Polypeptider, fremgangsmåder til deres fremstilling og analgetikum indeholdende et sådant polypeptid - Google Patents

Polypeptider, fremgangsmåder til deres fremstilling og analgetikum indeholdende et sådant polypeptid Download PDF

Info

Publication number
DK171300B1
DK171300B1 DK513385A DK513385A DK171300B1 DK 171300 B1 DK171300 B1 DK 171300B1 DK 513385 A DK513385 A DK 513385A DK 513385 A DK513385 A DK 513385A DK 171300 B1 DK171300 B1 DK 171300B1
Authority
DK
Denmark
Prior art keywords
arg
leu
gly
phe
tos
Prior art date
Application number
DK513385A
Other languages
Danish (da)
English (en)
Other versions
DK513385D0 (da
DK513385A (da
Inventor
Hiroshi Yoshino
Yutaka Tsuchiya
Takeru Kaneko
Takahiro Nakazawa
Masuhiro Ikeda
Shin Araki
Kiyomi Yamatsu
Shinro Tachibana
Yoshihiro Arakawa
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of DK513385D0 publication Critical patent/DK513385D0/da
Publication of DK513385A publication Critical patent/DK513385A/da
Application granted granted Critical
Publication of DK171300B1 publication Critical patent/DK171300B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/675—Beta-endorphins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK513385A 1984-11-09 1985-11-07 Polypeptider, fremgangsmåder til deres fremstilling og analgetikum indeholdende et sådant polypeptid DK171300B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59236076A JPH0680079B2 (ja) 1984-11-09 1984-11-09 ポリペプチド
JP23607684 1984-11-09

Publications (3)

Publication Number Publication Date
DK513385D0 DK513385D0 (da) 1985-11-07
DK513385A DK513385A (da) 1986-05-10
DK171300B1 true DK171300B1 (da) 1996-08-26

Family

ID=16995360

Family Applications (1)

Application Number Title Priority Date Filing Date
DK513385A DK171300B1 (da) 1984-11-09 1985-11-07 Polypeptider, fremgangsmåder til deres fremstilling og analgetikum indeholdende et sådant polypeptid

Country Status (21)

Country Link
US (1) US4707468A (no)
EP (2) EP0181001B1 (no)
JP (1) JPH0680079B2 (no)
KR (1) KR880000765B1 (no)
CN (1) CN1029684C (no)
AT (1) ATE135712T1 (no)
AU (1) AU588837B2 (no)
CA (1) CA1267997A (no)
DE (1) DE3588095T2 (no)
DK (1) DK171300B1 (no)
ES (1) ES8800272A1 (no)
FI (1) FI92935C (no)
GR (1) GR852689B (no)
HU (1) HU203563B (no)
IL (1) IL76924A (no)
NO (1) NO169347C (no)
NZ (1) NZ214122A (no)
PH (1) PH23847A (no)
PT (1) PT81441B (no)
SU (1) SU1433415A3 (no)
ZA (1) ZA858456B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2673376A1 (fr) * 1991-03-01 1992-09-04 Lefesvre Andre Composition pharmaceutique pour le traitement des tumeurs de kaposi.
US5817628A (en) * 1992-12-02 1998-10-06 The Rockefeller University Dynorphin a suppression of natural killer cell activity
SE9401596D0 (sv) * 1994-05-06 1994-05-06 Astra Ab New compounds
JP3385147B2 (ja) * 1996-01-31 2003-03-10 ユニ・チャーム株式会社 男性用尿とり袋
WO1997049422A1 (en) * 1996-06-24 1997-12-31 The Rockefeller University Method of using ligands of the kappa opioid receptor
IL138214A0 (en) * 1998-03-09 2001-10-31 Zealand Pharmaceuticals As Pharmacolgically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
US6232287B1 (en) * 1998-03-13 2001-05-15 The Burnham Institute Molecules that home to various selected organs or tissues
IL137820A (en) * 2000-08-10 2009-06-15 S I S Shulov Inst For Science Pharmaceutical composition for topical administration comprising an analgesic peptide
PT1486206E (pt) * 2000-08-25 2008-01-25 Res Corp Technologies Inc ¿utilizações para aminoácidos anticonvulsivantes para o tratamento de perturbações bipolares¿
DE60120104T2 (de) * 2001-03-20 2006-09-21 Schwarz Pharma Ag Neue Verwendung von Peptidverbindungen bei der Behandlung von nicht-neuropathischem Entzündungsschmerz
PT1243263E (pt) * 2001-03-21 2003-03-31 Sanol Arznei Schwarz Gmbh Nova utilizacao de uma classe peptidica de composto para o tratamento de alodinia ou de outros tipos diferentes de dor cronica ou fantasma
US7622446B2 (en) * 2001-04-18 2009-11-24 The Open University Polypeptides, derivatives and uses thereof
US7491702B2 (en) * 2001-04-18 2009-02-17 The Open University Polypeptides related to amyloid precursor protein, pharmaceutical compositions thereof, and methods of treatment using the same
US8008351B2 (en) 2004-04-16 2011-08-30 Ucb Pharma Gmbh Methods for prophylaxis or treatment of conditions associated with cortical spreading depression
EP1781276B1 (en) * 2004-08-27 2010-06-23 UCB Pharma GmbH Use of peptide compounds for treating bone cancer pain, chemotherapy- and nucleoside-induced pain
US20070043120A1 (en) * 2005-08-18 2007-02-22 Bettina Beyreuther Therapeutic combination for painful medical conditions
US20070048372A1 (en) * 2005-08-18 2007-03-01 Srz Properties, Inc. Method for treating non-inflammatory osteoarthritic pain
EP1754476A1 (en) * 2005-08-18 2007-02-21 Schwarz Pharma Ag Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia
GB2432586B (en) * 2005-11-25 2010-01-13 Univ Open Treatment of neurodegenerative disorders
EA027836B1 (ru) * 2006-06-15 2017-09-29 ЮСиБи ФАРМА ГМБХ Фармацевтическая комбинация для профилактики, облегчения и/или лечения приступов эпилепсии и ее применение
RU2010114029A (ru) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) Астрессин и бета-эндорфин для применения в качестве терапевтических средств
CA2698985A1 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
CN111182887A (zh) * 2017-06-14 2020-05-19 株式会社生物解决方案有限公司 用于改善皮肤皱纹或抗炎活性的包括物质p的化妆品组合物
EP4092038A1 (en) 2017-09-11 2022-11-23 Protagonist Therapeutics, Inc. Opioid agonist peptides and uses thereof
AU2021300202A1 (en) * 2020-07-01 2023-02-02 PreveCeutical Medical Inc. Peptides and uses thereof
RU2760133C1 (ru) * 2021-04-22 2021-11-22 Федеральное государственное бюджетное учреждение науки "Научный центр биомедицинских технологий Федерального медико-биологического агентства". Амиды гептапептида для лечения HMGB1-зависимых заболеваний

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2703109A1 (de) * 1976-01-26 1977-08-04 Wellcome Found Biologisch wirksame amide
US4254106A (en) * 1976-01-26 1981-03-03 Burroughs Wellcome Co. Biologically active amides
US4123523A (en) * 1976-06-21 1978-10-31 Imperial Chemical Industries Limited Analgesic and sedative polypeptides
US4371463A (en) * 1977-02-17 1983-02-01 The United States Of America As Represented By The Department Of Health And Human Services Enzyme-resistant opiate pentapeptides
US4081434A (en) * 1977-03-11 1978-03-28 Hoffmann-La Roche Inc. Novel analogs of β-endorphin
US4139504A (en) * 1977-06-16 1979-02-13 Coy David Howard Novel nonapeptides, intermediates therefor, and compositions and methods employing said nonapeptides
US4127533A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel octapeptides, intermediates therefor, and compositions and methods employing said octapeptides
GB1604850A (en) * 1977-11-24 1981-12-16 Wellcome Found Biologically active peptides
US4148786A (en) * 1978-06-26 1979-04-10 American Home Products Corporation Analgesic polypeptide
US4178284A (en) * 1978-12-11 1979-12-11 American Home Products Corporation Octapeptides
DE2936099A1 (de) * 1979-09-06 1981-04-02 Victor Dipl.- Chem. 8000 München Brantl Pharmakologisch aktive peptide
DE3163199D1 (en) * 1980-07-17 1984-05-24 Sandoz Ag Novel pentapeptides, processes for their production, pharmaceutical compositions comprising said pentapeptides and their use
JPS57134451A (en) * 1981-02-13 1982-08-19 Suntory Ltd Peptide opioide
DE3274798D1 (en) * 1981-10-05 1987-02-05 Nicholas P Plotnikoff Process for using endorphins as antitumour agents
US4462941A (en) * 1982-06-10 1984-07-31 The Regents Of The University Of California Dynorphin amide analogs
JPS59141547A (ja) * 1983-02-01 1984-08-14 Eisai Co Ltd 鎮痛作用を有する新規ペプタイドおよび製法
US4518711A (en) * 1983-05-16 1985-05-21 Gibson-Stephens Institute Conformationally constrained cyclic enkephalin analogs with delta receptor specificity

Also Published As

Publication number Publication date
DE3588095T2 (de) 1996-09-19
CN1029684C (zh) 1995-09-06
PT81441B (pt) 1987-11-11
US4707468A (en) 1987-11-17
EP0181001B1 (en) 1996-03-20
ES548667A0 (es) 1987-10-16
JPH0680079B2 (ja) 1994-10-12
NO169347B (no) 1992-03-02
ES8800272A1 (es) 1987-10-16
KR860004081A (ko) 1986-06-16
SU1433415A3 (ru) 1988-10-23
EP0614913A3 (en) 1997-06-04
PH23847A (en) 1989-11-23
ZA858456B (en) 1987-07-29
EP0181001A2 (en) 1986-05-14
ATE135712T1 (de) 1996-04-15
FI92935C (fi) 1995-01-25
JPS61115097A (ja) 1986-06-02
DK513385D0 (da) 1985-11-07
HU203563B (en) 1991-08-28
NO854435L (no) 1986-05-12
NZ214122A (en) 1988-08-30
FI854227L (fi) 1986-05-10
IL76924A (en) 1990-07-12
KR880000765B1 (en) 1988-05-06
PT81441A (en) 1985-12-01
EP0181001A3 (en) 1989-04-19
HUT40145A (en) 1986-11-28
IL76924A0 (en) 1986-04-29
AU4938985A (en) 1986-05-15
GR852689B (no) 1986-02-21
DK513385A (da) 1986-05-10
FI854227A0 (fi) 1985-10-28
FI92935B (fi) 1994-10-14
CN85109722A (zh) 1986-10-08
DE3588095D1 (de) 1996-04-25
NO169347C (no) 1992-06-10
AU588837B2 (en) 1989-09-28
CA1267997A (en) 1990-04-17
EP0614913A2 (en) 1994-09-14

Similar Documents

Publication Publication Date Title
DK171300B1 (da) Polypeptider, fremgangsmåder til deres fremstilling og analgetikum indeholdende et sådant polypeptid
JP2795449B2 (ja) 治療用ペプチド
EP0674652B1 (en) Dolastatin analog
US4003884A (en) Peptides having LH-RH/FSH-RH activity
NO301015B1 (no) Dekapeptid med antiovulatorisk aktivitet
WO1996040751A1 (en) Novel dolastatin derivatives, their preparation and use
HU208439B (en) Process for producing pharmaceutical peptides
JPH02289599A (ja) オクタペプチド
HU211603A9 (en) Nonapeptide bombesin antagonists
KR100286242B1 (ko) 돌라스타틴 유도체
US4128638A (en) Nona- and deca-peptide amide derivatives demonstrating high ovulation inducing activity
NO891006L (no) Terapeutisk aktivt polypeptid og fremgangsmaate for dets fremstilling.
US4705778A (en) Orally active LHRH analogs
CN102482323A (zh) 新型肽及其应用
US3749703A (en) Asn15-bovine thyrocalcitonin
CA2405704C (en) Bombesin analogs for treatment of cancer
HU205771B (en) Process for producing irreversible peptide ligands for bombesin receptors and process for producing pharmaceutical compositions comprising such peptides as active ingredient
EP0101929B1 (en) Polypeptide-diesters, their production and use
IE59556B1 (en) Therapeutic somatostatin analogs
EP0225746A2 (en) Therapeutic decapeptides
CA1338302C (en) Therapeutic octapeptide somatostatin analogs
IL97298A (en) History and vasotoxin and azo activity and pharmaceutical preparations containing them
US6989371B1 (en) Bombesin analogs for treatment of cancer
AU2533988A (en) Vasoactive peptides
EP0200512B1 (en) Peptides and their use in therapy

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK